11/6
08:07 am
aqst
Aquestive Therapeutics, Inc. (NASDAQ: AQST) had its "buy" rating re-affirmed by analysts at HC Wainwright. They now have a $10.00 price target on the stock.
Medium
Report
Aquestive Therapeutics, Inc. (NASDAQ: AQST) had its "buy" rating re-affirmed by analysts at HC Wainwright. They now have a $10.00 price target on the stock.
10/25
09:20 am
aqst
Rating for AQST
Low
Report
Rating for AQST
10/25
08:37 am
aqst
Aquestive Therapeutics, Inc. (NASDAQ: AQST) had its "buy" rating re-affirmed by analysts at HC Wainwright. They now have a $10.00 price target on the stock.
Low
Report
Aquestive Therapeutics, Inc. (NASDAQ: AQST) had its "buy" rating re-affirmed by analysts at HC Wainwright. They now have a $10.00 price target on the stock.
10/8
02:34 pm
aqst
Aquestive Therapeutics, Inc. (NASDAQ: AQST) had its "market outperform" rating re-affirmed by analysts at JMP Securities. They now have a $9.00 price target on the stock.
Low
Report
Aquestive Therapeutics, Inc. (NASDAQ: AQST) had its "market outperform" rating re-affirmed by analysts at JMP Securities. They now have a $9.00 price target on the stock.
10/8
02:34 pm
aqst
Aquestive Therapeutics, Inc. (NASDAQ: AQST) had its "market outperform" rating re-affirmed by analysts at JMP Securities. They now have a $9.00 price target on the stock.
Low
Report
Aquestive Therapeutics, Inc. (NASDAQ: AQST) had its "market outperform" rating re-affirmed by analysts at JMP Securities. They now have a $9.00 price target on the stock.
10/8
02:06 pm
aqst
Rating for AQST
Low
Report
Rating for AQST
10/8
02:06 pm
aqst
Rating for AQST
Low
Report
Rating for AQST
9/30
10:08 am
aqst
Aquestive Therapeutics, Inc. (NASDAQ: AQST) had its "market outperform" rating re-affirmed by analysts at JMP Securities. They now have a $9.00 price target on the stock.
Low
Report
Aquestive Therapeutics, Inc. (NASDAQ: AQST) had its "market outperform" rating re-affirmed by analysts at JMP Securities. They now have a $9.00 price target on the stock.
9/30
10:08 am
aqst
Aquestive Therapeutics, Inc. (NASDAQ: AQST) had its "market outperform" rating re-affirmed by analysts at JMP Securities. They now have a $9.00 price target on the stock.
Low
Report
Aquestive Therapeutics, Inc. (NASDAQ: AQST) had its "market outperform" rating re-affirmed by analysts at JMP Securities. They now have a $9.00 price target on the stock.
9/30
09:29 am
aqst
Rating for AQST
Medium
Report
Rating for AQST
9/30
09:29 am
aqst
Rating for AQST
Medium
Report
Rating for AQST
9/30
08:40 am
aqst
Aquestive Therapeutics, Inc. (NASDAQ: AQST) had its "outperform" rating re-affirmed by analysts at Leerink Partners. They now have a $12.00 price target on the stock, up previously from $10.00.
Medium
Report
Aquestive Therapeutics, Inc. (NASDAQ: AQST) had its "outperform" rating re-affirmed by analysts at Leerink Partners. They now have a $12.00 price target on the stock, up previously from $10.00.
9/30
08:07 am
aqst
Rating for AQST
Medium
Report
Rating for AQST